5989 Participants Needed

Vancomycin + Cefazolin for Surgical Site Infections

(PICS Trial)

Recruiting at 3 trial locations
RP
DM
Overseen ByDominik Mertz, MD, MSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hamilton Health Sciences Corporation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

There is clinical equipoise about the question of whether antibiotic prophylaxis should be given for a short period or an extended period of time as reflected by inconsistencies in major guidelines, current practices at Canadian centers, and as concluded in the three systematic reviews. There also is clinical equipoise on whether the addition of vancomycin to routine cefazolin prophylaxis can further reduce s-SSI rates. A short duration of combined antimicrobial prophylaxis can reduce side effects of exposure to antimicrobials such as infections with C. difficile or emergence of resistance, but may also reduce the incidence of s-SSIs. The objective of the eventual full scale study is to determine whether adding vancomycin to cefazolin can reduce SSIs as well as whether short-term prophylaxis is as effective as long-term prophylaxis. The rationale to conduct the proposed pilot study is to assess the feasibility to conduct this factorial cluster randomized cross-over trial, the adherence to the study protocol at each pilot site, the length of time to fill out the case report forms, and to get reliable estimates of event rates for sample size calculation for the main study

Research Team

Preventing AMR in hospitals: Q&A with ...

Dominik Mertz, MD

Principal Investigator

Hamilton Health Sciences Corporation

Eligibility Criteria

Adults (18+) needing open-heart surgery can join this trial. It's not for those already on antibiotics, previous participants, known MRSA carriers, people allergic to beta-lactams that prevent cefazolin use, or anyone in another interfering study.

Inclusion Criteria

I am 18 or older and will have open-heart surgery.

Exclusion Criteria

Beta-lactam allergy (IgE-mediated) precluding the use of cefazolin
I am a known carrier of MRSA.
Previous enrollment in this trial
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either cefazolin monotherapy or combination therapy with vancomycin, with short or long course regimens administered around the time of surgery

2-3 days

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of surgical site infections and other outcomes

3 months

Treatment Details

Interventions

  • Cefazolin
  • Vancomycin
Trial Overview The trial is testing if adding vancomycin to standard cefazolin before heart surgery prevents infections better and whether short-term antibiotic use is as good as long-term. It's a pilot study to see if a larger trial would work.
Participant Groups
4Treatment groups
Experimental Treatment
Group I: Combination therapy, short courseExperimental Treatment2 Interventions
One pre-op dose of cefazolin 30-60 minutes prior to surgery followed by a second dose either four hours after the first dose or upon wound closure (whatever comes first) will be administered. In addition, one dose of vancomycin 60-90min pre-op will be administered.
Group II: Combination therapy, long courseExperimental Treatment2 Interventions
One pre-op dose of cefazolin 30-60 minutes prior to surgery followed by a second dose either four hours after the first dose or upon wound closure (whatever comes first) will be administered followed by additional five doses every eight hours postoperatively (last dose 44 hours after the first dose). In addition, one dose of vancomycin 60-90min pre-op will be administered followed by 3 post-op doses every 12 hours (last dose 36 hours after first dose)
Group III: Cefazolin monotherapy, short courseExperimental Treatment1 Intervention
One pre-op dose of cefazolin 30-60 minutes prior to surgery followed by a second dose either four hours after the first dose or upon wound closure (whatever comes first) will be administered
Group IV: Cefazolin monotherapy, long courseExperimental Treatment1 Intervention
One pre-op dose of cefazolin 30-60 minutes prior to surgery followed by a second dose either four hours after the first dose or upon wound closure (whatever comes first) will be administered followed by additional five doses every eight hours postoperatively (last dose 44 hours after the first dose).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hamilton Health Sciences Corporation

Lead Sponsor

Trials
380
Recruited
345,000+

The Physicians' Services Incorporated Foundation

Collaborator

Trials
165
Recruited
31,700+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security